Properties of Fujicalin((R)), a new modified anhydrous dibasic calcium phosphate for direct compression: Comparison with dicalcium phosphate dihydrate

Citation
H. Schlack et al., Properties of Fujicalin((R)), a new modified anhydrous dibasic calcium phosphate for direct compression: Comparison with dicalcium phosphate dihydrate, DRUG DEV IN, 27(8), 2001, pp. 789-801
Citations number
28
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
ISSN journal
03639045 → ACNP
Volume
27
Issue
8
Year of publication
2001
Pages
789 - 801
Database
ISI
SICI code
0363-9045(2001)27:8<789:POFANM>2.0.ZU;2-X
Abstract
The novel, commercially available, free-flowing spherically granulated dica lcium phosphate anhydrous (SGDCPA) Fujicalin for direct tableting it,as com pared with directly compressible dicalcium phosphate dihydrate (DCPD), the properties of which are well known. The two excipients tt,ere investigated and compared with regard to their physical and powder properties, compressi bility, and compactibility. As a consequence of the spherical shape of its particles, SGDCPA shows the same good flowability and even better compactib ility. In contrast to DCPD, SGDCPA shows significant uptake of moisture whe n exposed to relative humidities (RHs) exceeding 70%. For both excipients, the main deformation mechanism is fragmentation, with SGDCPA Yielding signi ficantly stronger tablets.